| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 03/23/2006 | US20060063200 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 03/23/2006 | US20060063174 MicroRNA vectors |
| 03/23/2006 | US20060063150 Antisense antiviral compound and method for treating ssRNA viral infection |
| 03/23/2006 | US20060062855 Therapeutic calcium phosphate particles for use in inhibiting expression of a gene |
| 03/23/2006 | US20060062841 Liposomal vectors |
| 03/23/2006 | US20060062803 a nucleic acid fhaving a first nucleotide sequence encoding nonstructural proteins from attenuated dengue-2 virus vaccine strain PDK-53, and a second nucleotide sequence encoding a structural protein from a second flavivirus; amino acid mutations in the nontstructural proteins; vaccines |
| 03/23/2006 | US20060062801 Immunogens; electrical injection; electroporation |
| 03/23/2006 | US20060062800 Immunogens; envelope proteins; kits |
| 03/23/2006 | US20060062798 Vaccines |
| 03/23/2006 | US20060062792 Novel human p53 splice variant displaying differential transcriptional activity |
| 03/23/2006 | US20060062790 AKT3 inhibitors |
| 03/23/2006 | US20060062788 Method for determining MIF content |
| 03/23/2006 | US20060062785 Inhibition of pacap signalling for the prevention and treatment of thrombocytopenia |
| 03/23/2006 | US20060062782 Anti-IgE vaccines |
| 03/23/2006 | US20060062777 Inhibit tumor growth, or metastasis by modifying protein-protein interactions involving certain amino acid sequences within matrix metalloproteinase 9 (MMP-9) |
| 03/23/2006 | US20060062772 Polypeptide delivery system |
| 03/23/2006 | US20060062769 Using nestin-positive pancreatic stem cell to generate insulin producing beta cells; tissue engineering and repair; regenerative medicine |
| 03/23/2006 | US20060062765 Lentiviral vector-mediated gene transfer and uses thereof |
| 03/23/2006 | US20060062764 Fiber-modified adenoviral vectors for enhanced transduction of tumor cells |
| 03/23/2006 | US20060062074 Method for intracellular modifications within living cells using pulsed electric fields |
| 03/23/2006 | DE102004043155A1 Hochspezifisch mit DNA interagierende Enzym-Konjugate mit programmierbarer Spezifität Highly specific interacting with DNA enzyme conjugates with programmable specificity |
| 03/23/2006 | CA2580560A1 Compositions and methods for inhibiting expression of anti-apoptotic genes |
| 03/23/2006 | CA2580537A1 Compositions and their uses for lysosomal enzyme deficiencies |
| 03/23/2006 | CA2579292A1 Isolated lineage negative hematopoietic stem cells and methods of treatment therewith |
| 03/23/2006 | CA2577989A1 Cytokine-expressing cellular vaccines for treatment of prostate cancer |
| 03/23/2006 | CA2576055A1 Methods and compositions for cell activation |
| 03/22/2006 | EP1637614A2 Nucleic acids and antibodies for detection of ISAV (infectious salmon anaemia virus) |
| 03/22/2006 | EP1637608A2 Recombinant adenoviral vector and methods of use |
| 03/22/2006 | EP1637601A2 Proteins, polynucleotides encoding them and methods of using the same |
| 03/22/2006 | EP1637600A1 Chromosome 1 gene and gene products related to Alzheimer's disease |
| 03/22/2006 | EP1637597A1 Method of nucleic acid infusion |
| 03/22/2006 | EP1637592A1 Neuronal progenitor cells, methods to produce them and uses thereof for the therapy of neural defects |
| 03/22/2006 | EP1636387A2 Methods and nucleic acids for the analysis of colorectal cell proliferative disorders |
| 03/22/2006 | EP1636384A2 Gene amplification and overexpression in cancer |
| 03/22/2006 | EP1636376A2 Differential gene expression in schizophrenia |
| 03/22/2006 | EP1636370A2 Methods of generating chimeric adenoviruses and uses for such chimeric adenoviruses |
| 03/22/2006 | EP1636359A2 Methods for treating pain |
| 03/22/2006 | EP1636336A2 Smooth muscle progenitor cells |
| 03/22/2006 | EP1636262A1 Interferon gamma-like protein |
| 03/22/2006 | EP1636260A2 Improved secretion of neublastin |
| 03/22/2006 | EP1635860A2 Use of vegf-c or vegf-d in reconstructive surgery |
| 03/22/2006 | EP1635763A2 Method of treating neurodegenerative disease |
| 03/22/2006 | EP1546360A4 Method of analyzing non-complexed forms of prostate specific antigen in a sample to improve prostate cancer detection |
| 03/22/2006 | EP1490478A4 Method for production of neutrophils and uses therefor |
| 03/22/2006 | EP1461436A4 Polycationic water soluble copolymer and method for transferring polyanionic macromolecules across biological barriers |
| 03/22/2006 | EP1322287B1 Microparticles for delivery of the heterologous nucleic acids |
| 03/22/2006 | EP1149171B1 Foamy virus vectors for expressing foreign genes in mammals and the use thereof |
| 03/22/2006 | EP1129191B1 Methods of diagnosing or treating neurological diseases |
| 03/22/2006 | EP1005480B1 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases |
| 03/22/2006 | EP0914456B1 Gene expression in monocytes and macrophages |
| 03/22/2006 | EP0864645B9 Negative-strand rna virus vector having autonomously replicating activity |
| 03/22/2006 | EP0789564B1 Polynucleotide compositions |
| 03/22/2006 | CN1750843A Methods and compositions for inducing apoptosis in cancer cells |
| 03/22/2006 | CN1750834A Combination therapy for treating protein deficiencies |
| 03/22/2006 | CN1749397A Bi-recombinant active carrier vaccine of co-expression pig gyrate virus and foot and mouth disease virus |
| 03/22/2006 | CN1749395A Cloning and expression of Japan blood flukes SJCXSWL 02 gene and DNA vaccine |
| 03/22/2006 | CN1749394A Cloning and expression of Japan blood flukes HGPRT gene and DNA vaccine |
| 03/22/2006 | CN1749277A Heat shock protein 65-human SARS coronary virus epitope antigen recombinant fusion protein (HSP65SARS/3CL161-264) |
| 03/22/2006 | CN1748797A Polyepitope DNA vaccine of anti-simple herpes virus-2 infection and its preparing method |
| 03/22/2006 | CN1748796A Tuberculosis transgenic vaccine and its preparing method |
| 03/22/2006 | CN1748795A Polyvalent avian flu recombinant live carrier vaccine |
| 03/22/2006 | CN1748787A Pharmaceutical preparation containing p40 molecule or its gene |
| 03/22/2006 | CN1246481C Use of Ard1 gene |
| 03/22/2006 | CN1246458C Human cervical cancer 2 protooncogene and protein encoded therein |
| 03/22/2006 | CN1246333C Receptor in the EDb Fibronection domain |
| 03/22/2006 | CN1246329C Mouse tumor generating and metastasis promoting acceptor and its encoding gene and application |
| 03/22/2006 | CA2482380A1 Beta-parvin expression for use in diagnostic methods for assessment of breast cancer |
| 03/21/2006 | US7015316 persephin is a member of the GDNF-Neurturin family of growth factors; Glial-derived neurotrophic factor (GDNF); promotes survival of mesencephalic neuronal cells; nucleic acids of given sequences |
| 03/21/2006 | US7015315 first region having 2'-O-alkyl substituted nucleotide units where the alkyl has at least 2 carbon atoms, and a second region having 2'-deoxy sugar moieties, and which includes phosphorothioate linkages; nuclease resistance; hybridizes to single stranded DNA or RNA |
| 03/21/2006 | US7015311 That binds to a neurturin polypeptide of given sequences that promotes survival of superior cervical ganglion cells or nodose ganglion cells; can be used to detect and monitor patient levels of neurturin |
| 03/21/2006 | US7015205 Melanoma vaccine and methods of making and using same |
| 03/21/2006 | US7015204 Protective immunity or immunological tolerance induced with RNA particularly total cellular RNA |
| 03/21/2006 | US7015192 synthetic hexapeptides or oligopeptides used as neurosecretion antagonists; bloking release of catecholamines; wrinkling and aging resistance |
| 03/21/2006 | US7015190 Administering peptides, mimetics or nucleic acids to interfere with cAMP binding proteins or with DNA so as to derepress cAMP-responsive gene expression; cognition activators; learning enhancement |
| 03/21/2006 | US7015040 Intravascular delivery of nucleic acid |
| 03/21/2006 | US7015037 Multiponent adult stem cells and methods for isolation |
| 03/21/2006 | US7015017 Process and agent for instabilizing viral quasi-species-distributions avoiding resistance phenomena |
| 03/21/2006 | US7015015 Nucleotide sequences coding polypeptide for use in treatment of diabetes, epilepsy, depression, ischemia and muscle disorders |
| 03/21/2006 | US7014847 Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders |
| 03/21/2006 | US7014838 Use of biomolecular targets in the treatment and visualization of brain tumors |
| 03/17/2006 | CA2477867A1 Peptides, dna's, rna's, and compounds for inhibiting or inducing adrenomedullin activity, and use of the same |
| 03/16/2006 | WO2006029347A2 Integrin cd18 is a novel stromal stem cell marker and functions to promote osteogenesis |
| 03/16/2006 | WO2006029161A2 Cell specific gene silencing using cell-specific promoters in vitro and in vivo |
| 03/16/2006 | WO2006029005A2 Promoter substitution for immunoglobulin therapy |
| 03/16/2006 | WO2006028492A2 hC1Q/TNF7 AND USES THEREOF |
| 03/16/2006 | WO2006028160A1 S-oligonucleotide conjugate and antisense agent |
| 03/16/2006 | WO2005118813A3 Nucleic acids, polypeptides, methods of expression, and immunogenic compositions associated with sars corona virus spike protein |
| 03/16/2006 | WO2005110013A3 Methods, compositions, and preparations for delivery of immune response modifiers |
| 03/16/2006 | WO2005091992A3 Oligonucleotide compositions targeting egr-1 forcancer treatment |
| 03/16/2006 | WO2005090994A3 Diagnostics and therapeutics for diseases associated with protein kinase, cgmp-dependent, type i (prkg1) |
| 03/16/2006 | WO2005087926A3 Multiple promoter expression cassettes for simultaneous delivery of rnai agents |
| 03/16/2006 | WO2005030260A8 Bispecific oligonucleotide for the treatment of cns malignancies |
| 03/16/2006 | WO2004000220A3 Methods for purifying viral particles for gene therapy |
| 03/16/2006 | US20060059577 Melusin a muscle specific protein, as a drug target for prevention and treatment of heart failure |
| 03/16/2006 | US20060058508 Novel functional peptide nucleic acid and process for producing the same |
| 03/16/2006 | US20060058507 Krib polynucleotides and polypeptides and uses thereof in the treatment of metabolic disorders |
| 03/16/2006 | US20060058505 Nucleic acid and polypeptide linked to breast cancer and uses therefor |
| 03/16/2006 | US20060058266 containing 2'-O-methyl modified nucleoside; oligonucleotide having a nucleotide sequence consisting of from 12 to 23 nucleotides in length sufficiently complementary to a microRNA target sequence of about 12 to 23 nucleotides, conjugate with a cholesterol or steroid; for inhibiting gene expression |
| 03/16/2006 | US20060058258 Gene transcription and ionizing radiation: methods and compositions |
| 03/16/2006 | US20060058257 Influencing angiogenesis using CD66a |